MYO-SEQ

MYO-SEQ

Picture31  
  • About
  • Team
  • Collaborators
  • Patient Registries
    • Congenital Muscular Dystrophy, Congenital Myopathy and Congenital Myasthenic Syndrome
    • LGMD2A
    • LGMD2B
    • LGMD2C
    • LGMD2D
    • LGMD2I
    • Pompe Disease
  • Useful information
  • Frequently asked questions
  • Contact
Home Inclusion Criteria

Inclusion Criteria

Patients who are eligible for inclusion in the MYO-SEQ project must present with:

Unexplained limb-girdle muscle weakness at 10 years of age or over, in combination with

  • elevated serum creatine kinase activity, with or without
  • unexplained respiratory dysfunction

About the project

  • About the project
    • Mission statement
    • Inclusion Criteria

John Walton Muscular Dystrophy Research Centre
Institute of Genetic Medicine
Newcastle University
International Centre for Life
Central Parkway
Newcastle upon Tyne
NE1 3BZ
United Kingdom

Our privacy policy

John Walton Muscular Dystrophy Research Centre - Log in

This site uses cookies: Find out more.